Network Database for Drug Labeling Information Management
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current paper-based package inserts for drug labeling are costly, time-consuming to update, and result in pharmacists and physicians often accessing outdated information, with poor readability and significant delays in disseminating new or revised labeling information.
Innovation Solution
A network-accessible database system that allows pharmaceutical manufacturers to upload and pharmacists to download up-to-date drug labeling information via the Internet, eliminating the need for physical paper-based labels, with real-time updates and searchable PDF documents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of information
If paper-based package inserts are used for drug labeling, then prescribing information is provided to pharmacists, but significant expenses are incurred in printing, labor, warehousing, and quality assurance
Solution Approach 1:
The patent replaces the mechanical paper-based package insert system with an electronic database system accessible via the Internet. The database stores prescribing information and allows pharmacists to access it electronically, eliminating the need for physical printing, folding, and distribution of paper inserts. This substitution of mechanical processes with electronic information management resolves the contradiction between providing information access and reducing operational expenses.
Solution Approach 2:
The patent creates electronic copies of prescribing information stored in a database that can be accessed and displayed on computer screens. Instead of producing physical copies through printing and distribution, the system generates digital replicas of the labeling information that can be instantly retrieved and viewed by pharmacists, thereby eliminating the costs associated with paper production and physical distribution while maintaining information accessibility.
2Loss of information
If paper-based package inserts are produced and distributed, then labeling information is provided to pharmacists, but significant time delays occur in updating and disseminating new or revised labeling
Solution Approach 1:
The patent replaces the slow mechanical process of printing, distributing, and updating physical package inserts with an electronic database system connected to the Internet. When labeling information needs to be updated, the database is modified electronically and the changes are instantly available to all pharmacists who access the system, eliminating the weeks-long delay inherent in the paper-based redistribution process.
Solution Approach 2:
The patent establishes a centralized database that maintains current prescribing information in advance, allowing pharmacists to access updated labeling before it would be physically distributed through traditional channels. The system proactively makes new information available as soon as it is entered into the database, rather than waiting for the next printing and distribution cycle.
3Loss of information
If package inserts are physically attached to drug containers, then prescribing information is provided, but poor readability occurs due to small font sizes and oversized formats
Solution Approach 1:
The patent replaces the physical paper insert with an electronic display system that presents prescribing information on a computer screen. The electronic format allows for larger, more readable text and graphics without increasing the physical size of the container, and the information can be displayed at optimal font sizes and layouts that enhance readability while maintaining all necessary prescribing details.
Solution Approach 2:
The patent transitions the prescribing information from a two-dimensional paper format constrained by the size of the drug container to a digital display format that utilizes the screen's display area. This dimensional change allows the same information to be presented in a much more readable format with larger text and better spacing, as the electronic display is not constrained by the physical dimensions of the medication container.
4Reliability
If multiple steps are required to produce and place package inserts, then prescribing information is finalized and distributed, but the process takes several weeks for new products and even longer for revisions
Solution Approach 1:
The patent replaces the multi-step mechanical process of typesetting, printing, folding, and distributing paper inserts with a streamlined electronic system. The database accepts prescribing information in digital format, stores it, and makes it immediately accessible to pharmacists, eliminating the sequential steps of printing and physical distribution while maintaining the necessary review and approval processes for information accuracy.
Solution Approach 2:
The patent merges the functions of information creation, storage, distribution, and updating into a single integrated electronic database system. Instead of separate processes for typesetting, printing, warehousing, and distribution, all these functions are combined into one digital platform that handles the complete lifecycle of prescribing information management, thereby dramatically reducing the time required while maintaining reliability through centralized control.
Data Source
AI summary
A system for managing drug labeling information includes a repository comprising a network accessible database, the repository having an upload portion and a download portion, the repository being accessible to a plurality of users via client computers coupled to a wide area network. The repository includes drug labeling information on a plurality of drugs stored therein. The upload portion of the repository is accessible by a first set of users while the download portion of the repository is accessible by a second set of users. In one preferred aspect of the invention, drug manufactures are able to upload new or revised PDF files containing drug labeling information. The new or revised PDF files are then available for download by pharmacists or other authorized users.